Journal list menu
Export Citations
Download PDFs
Issue Information
Review
Open Access
oa
Non-alcoholic fatty liver disease and heart failure with preserved ejection fraction: from pathophysiology to practical issues
- Pages: 789-798
- First Published: 03 February 2021
Perspective
Open Access
oa
A New Requirement for Publication: Access to Effective Drugs for Ethical Reasons, The Example of Heart Failure
- Pages: 799-801
- First Published: 09 February 2021
Review
Open Access
oa
Impact of primary care involvement and setting on multidisciplinary heart failure management: a systematic review and meta-analysis
- Pages: 802-818
- First Published: 06 January 2021
Original Research Articles
Open Access
oa
Prognostic impact of 6 min walk test distance in patients with systolic heart failure: insights from the WARCEF trial
- Pages: 819-828
- First Published: 30 December 2020
Open Access
oa
The diagnostic and prognostic value of galectin-3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST-CHF study
- Pages: 829-841
- First Published: 10 February 2021
Short Communication
Open Access
oa
Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT
- Pages: 842-848
- First Published: 14 February 2021
Original Research Articles
Open Access
oa
INTERVENE-HF: feasibility study of individualized, risk stratification-based, medication intervention in patients with heart failure with reduced ejection fraction
- Pages: 849-860
- First Published: 01 February 2021
Open Access
oa
Patient factors associated with titration of medical therapy in patients with heart failure with reduced ejection fraction: data from the QUALIFY international registry
- Pages: 861-871
- First Published: 10 February 2021
Open Access
oa
Functional outcomes with Carillon device over 1 year in patients with functional mitral regurgitation of Grades 2+ to 4+: results from the REDUCE-FMR trial
- Pages: 872-878
- First Published: 22 February 2021
Open Access
oa
Electrocardiographic features and their echocardiographic correlates in peripartum cardiomyopathy: results from the ESC EORP PPCM registry
- Pages: 879-889
- First Published: 16 January 2021
Open Access
oa
Myocardial deformation assessed among heart failure entities by cardiovascular magnetic resonance imaging
- Pages: 890-897
- First Published: 04 February 2021
Open Access
oa
Quantifying the relationship and contribution of mitochondrial respiration to systemic exercise limitation in heart failure
- Pages: 898-907
- First Published: 20 February 2021
Open Access
oa
Comparison of levosimendan, NO, and inhaled iloprost for pulmonary hypertension reversibility assessment in heart transplant candidates
- Pages: 908-917
- First Published: 23 February 2021
Open Access
oa
Sacubitril/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload
- Pages: 918-927
- First Published: 26 January 2021
Open Access
oa
Doxorubicin-induced and trastuzumab-induced cardiotoxicity in mice is not prevented by metoprolol
- Pages: 928-937
- First Published: 02 February 2021
Short Communication
Open Access
oa
Low-fat hypocaloric diet reduces neprilysin in overweight and obese human subjects
- Pages: 938-942
- First Published: 27 February 2021
Original Research Articles
Open Access
oa
Worsening of heart failure by coronavirus disease 2019 is associated with high mortality
- Pages: 943-952
- First Published: 26 January 2021
Open Access
oa
Impella versus extracorporal life support in cardiogenic shock: a propensity score adjusted analysis
- Pages: 953-961
- First Published: 09 February 2021
Open Access
oa
Cardio-microcurrent device for chronic heart failure: first-in-human clinical study
- Pages: 962-970
- First Published: 09 February 2021
Case Report
Open Access
oa
COVID-19-convalescence phase unmasks a silent myocardial infarction due to coronary plaque rupture
- Pages: 971-973
- First Published: 06 January 2021
Reviews
Open Access
oa
Pleiotropic activity of nerve growth factor in regulating cardiac functions and counteracting pathogenesis
- Pages: 974-987
- First Published: 19 January 2021
Open Access
oa
Cardiogenic shock teams and centres: a contemporary review of multidisciplinary care for cardiogenic shock
- Pages: 988-998
- First Published: 16 January 2021
Open Access
oa
Beyond the stethoscope: managing ambulatory heart failure during the COVID-19 pandemic
- Pages: 999-1006
- First Published: 27 January 2021
Open Access
oa
Sarcopenia in heart failure: a systematic review and meta-analysis
- Pages: 1007-1017
- First Published: 11 February 2021
Original Research Articles
Open Access
oa
Nurse-led ambulatory care supported by non-invasive haemodynamic assessment after acute heart failure decompensation
- Pages: 1018-1026
- First Published: 18 January 2021
Open Access
oa
Prognostic impacts of serum uric acid levels in patients with chronic heart failure: insights from the CHART-2 study
- Pages: 1027-1038
- First Published: 30 December 2020
Open Access
oa
Persistent mitral regurgitation after left ventricular assist device: a clinical conundrum
- Pages: 1039-1046
- First Published: 20 January 2021
Open Access
oa
Early use of remote dielectric sensing after hospitalization to reduce heart failure readmissions
- Pages: 1047-1054
- First Published: 18 December 2020
Open Access
oa
Characteristics and prognostic value of right ventricular (dys)function in patients with non-ischaemic dilated cardiomyopathy assessed with cardiac magnetic resonance imaging
- Pages: 1055-1063
- First Published: 09 February 2021
Open Access
oa
Veno-Arterial Extracorporeal Life Support in Heart Transplant and Ventricle Assist Device Centres. Meta-analysis
- Pages: 1064-1075
- First Published: 18 December 2020
Open Access
oa
The prehospital patient pathway and experience of care with acute heart failure: a comparison of two health care systems
- Pages: 1076-1084
- First Published: 24 December 2020
Open Access
oa
Transient heart rate reduction improves acute decompensated heart failure-induced left ventricular and coronary dysfunction
- Pages: 1085-1095
- First Published: 20 January 2021
Open Access
oa
Heart rate kinetics during standard cardiopulmonary exercise testing in heart transplant recipients: a longitudinal study
- Pages: 1096-1105
- First Published: 08 January 2021
Open Access
oa
Prognostic value of cardiac 123I-metaiodobenzylguanidine imaging for predicting cardiac events after transcatheter aortic valve replacement
- Pages: 1106-1116
- First Published: 05 January 2021
Open Access
oa
Prevalence and determinants of systolic and diastolic cardiac dysfunction and heart failure in acute ischemic stroke patients: The SICFAIL study
- Pages: 1117-1129
- First Published: 22 December 2020
Open Access
oa
Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the TOPCAT trial
- Pages: 1130-1138
- First Published: 12 January 2021
Open Access
oa
Characteristics, treatment, and outcomes of newly diagnosed atrial fibrillation patients with heart failure: GARFIELD-AF
- Pages: 1139-1149
- First Published: 12 January 2021
Open Access
oa
Impact of telemedicine on the management of heart failure patients during coronavirus disease 2019 pandemic
- Pages: 1150-1155
- First Published: 09 February 2021
Open Access
oa
Modification of ventriculo–arterial coupling by spironolactone in nonischemic dilated cardiomyopathy
- Pages: 1156-1166
- First Published: 05 January 2021
Open Access
oa
Incremental prognostic value of cardiac metaiodobenzylguanidine imaging over the co-morbid burden in acute decompensated heart failure
- Pages: 1167-1177
- First Published: 12 January 2021
Open Access
oa
Plasma growth differentiation factor 15: a novel tool to detect early changes of hereditary transthyretin amyloidosis
- Pages: 1178-1185
- First Published: 30 December 2020
Open Access
oa
Healthcare quality and mortality among patients hospitalized for heart failure by hospital level in Beijing, China
- Pages: 1186-1194
- First Published: 05 January 2021
Open Access
oa
Impact of QRS morphology on response to conduction system pacing after atrioventricular junction ablation
- Pages: 1195-1203
- First Published: 04 January 2021
Open Access
oa
Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
- Pages: 1204-1215
- First Published: 06 January 2021
Open Access
oa
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance
- Pages: 1216-1229
- First Published: 10 February 2021
Open Access
oa
Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension
- Pages: 1230-1243
- First Published: 05 January 2021
Open Access
oa
Predictive value of H2FPEF score in patients with heart failure with preserved ejection fraction
- Pages: 1244-1252
- First Published: 05 January 2021
Open Access
oa
Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation
- Pages: 1253-1262
- First Published: 21 January 2021
Open Access
oa
An aetiology-based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH-HF) trial
- Pages: 1263-1273
- First Published: 01 February 2021
Open Access
oa
Prognostic value of impaired hepato-renal function and liver fibrosis in patients admitted for acute heart failure
- Pages: 1274-1283
- First Published: 20 January 2021
Open Access
oa
The prevalence, predictors, and outcomes of spontaneous echocardiographic contrast or left ventricular thrombus in patients with HFrEF
- Pages: 1284-1294
- First Published: 25 January 2021
Open Access
oa
Temporal trends in incidence, causes, use of mechanical circulatory support and mortality in cardiogenic shock
- Pages: 1295-1303
- First Published: 19 February 2021
Open Access
oa
Iron deficiency impacts prognosis but less exercise capacity in heart failure with preserved ejection fraction
- Pages: 1304-1313
- First Published: 31 January 2021
Open Access
oa
Risk of in-hospital life-threatening ventricular arrhythmia or death after ST-elevation myocardial infarction vs. the Takotsubo syndrome
- Pages: 1314-1323
- First Published: 28 January 2021
Open Access
oa
The impact of COVID-19 on the management of heart failure: a United Kingdom patient questionnaire study
- Pages: 1324-1332
- First Published: 18 January 2021
Open Access
oa
Clinical profile and midterm prognosis of left ventricular thrombus in heart failure
- Pages: 1333-1341
- First Published: 25 February 2021
Open Access
oa
High-protein vs. standard-protein diets in overweight and obese patients with heart failure and diabetes mellitus: findings of the Pro-HEART trial
- Pages: 1342-1348
- First Published: 27 January 2021
Open Access
oa
Development and implementation of a remote patient monitoring program for heart failure: a single-centre experience
- Pages: 1349-1358
- First Published: 27 January 2021
Open Access
oa
A clinical score for predicting left ventricular reverse remodelling in patients with dilated cardiomyopathy
- Pages: 1359-1368
- First Published: 20 January 2021
Open Access
oa
Usefulness of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients
- Pages: 1369-1377
- First Published: 27 January 2021
Open Access
oa
Predicting the clinical course in hypertrophic cardiomyopathy using thallium-201 myocardial scintigraphy
- Pages: 1378-1387
- First Published: 12 February 2021
Open Access
oa
Hospital readmissions of patients with heart failure from real world: timing and associated risk factors
- Pages: 1388-1397
- First Published: 17 February 2021
Open Access
oa
Mortality risk prediction in elderly patients with cardiogenic shock: results from the CardShock study
- Pages: 1398-1407
- First Published: 31 January 2021
Open Access
oa
Fluid overload in patients undergoing TAVR: what we can learn from the nephrologists
- Pages: 1408-1416
- First Published: 13 February 2021
Open Access
oa
The effect of three major co-morbidities on quality of life and outcome of patients with heart failure with reduced ejection fraction
- Pages: 1417-1426
- First Published: 29 January 2021
Open Access
oa
Endothelial NADPH oxidase 4 protects against angiotensin II-induced cardiac fibrosis and inflammation
- Pages: 1427-1437
- First Published: 29 January 2021
Open Access
oa
Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid-range ejection fraction
- Pages: 1438-1445
- First Published: 22 February 2021
Open Access
oa
Prevalence of low health literacy levels in decompensated heart failure compared with acute myocardial infarction patients
- Pages: 1446-1459
- First Published: 05 February 2021
Open Access
oa
The course of patients with Chagas heart disease during episodes of decompensated heart failure
- Pages: 1460-1471
- First Published: 17 February 2021
Open Access
oa
Predicting outcome in children with dilated cardiomyopathy: the use of repeated measurements of risk factors for outcome
- Pages: 1472-1481
- First Published: 05 February 2021
Open Access
oa
Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program
- Pages: 1482-1493
- First Published: 17 February 2021
Open Access
oa
Prognostic impact of elevated fatty acid-binding protein 1 in patients with heart failure
- Pages: 1494-1501
- First Published: 04 February 2021
Open Access
oa
Eligibility for subcutaneous implantable cardioverter-defibrillator in adults with congenital heart disease
- Pages: 1502-1508
- First Published: 03 February 2021
Open Access
oa
Diagnosis and Treatment of Iron Deficiency in Heart Failure: OFICSel study by the French Heart Failure Working Group
- Pages: 1509-1521
- First Published: 22 February 2021
Open Access
oa
Aortic pulsatility index predicts clinical outcomes in heart failure: a sub-analysis of the ESCAPE trial
- Pages: 1522-1530
- First Published: 17 February 2021
Open Access
oa
Comparison of left ventricular longitudinal systolic function parameters in the prediction of adverse outcome in heart failure with preserved ejection fraction
- Pages: 1531-1540
- First Published: 11 February 2021
Open Access
oa
Clinical and economic impact of HeartLogic™ compared with standard care in heart failure patients
- Pages: 1541-1551
- First Published: 22 February 2021
Open Access
oa
The impact of frailty according to Clinical Frailty Scale on clinical outcome in patients with heart failure
- Pages: 1552-1561
- First Published: 06 February 2021
Open Access
oa
Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction
- Pages: 1562-1570
- First Published: 09 February 2021
Open Access
oa
Multiparameter diagnostic sensor measurements during clinically stable periods and worsening heart failure in ambulatory patients
- Pages: 1571-1581
- First Published: 22 February 2021
Open Access
oa
Stroke and systemic embolism in patients with atrial fibrillation and heart failure according to heart failure type
- Pages: 1582-1589
- First Published: 25 February 2021
Open Access
oa
Changes in cardiac sympathetic nerve activity on 123I-metaiodobenzylguanidine scintigraphy after MitraClip therapy
- Pages: 1590-1595
- First Published: 19 February 2021
Open Access
oa
Propensity score-based analysis of long-term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support
- Pages: 1596-1603
- First Published: 26 February 2021
Case Reports
Open Access
oa
The multiple faces of autoimmune/immune-mediated myocarditis in children: a biopsy-proven case series treated with immunosuppressive therapy
- Pages: 1604-1609
- First Published: 16 January 2021
Open Access
oa
Heart failure with preserved ejection fraction in coronavirus disease 2019 patients: the promising role of diuretic therapy in critically ill patients
- Pages: 1610-1614
- First Published: 14 January 2021
Open Access
oa
Regression of severe heart failure after combined left ventricular assist device placement and sleeve gastrectomy
- Pages: 1615-1619
- First Published: 24 January 2021
Open Access
oa
The diagnosis of a giant cardiac malignant lymphoma in the right ventricle: a case report
- Pages: 1620-1626
- First Published: 02 February 2021
Open Access
oa
Extracorporeal membrane oxygenation-assisted emergency percutaneous treatment of left ventricular assist device graft occlusion
- Pages: 1627-1630
- First Published: 26 January 2021
Open Access
oa
Pump thrombosis and dynamic outflow graft compression: complications in left ventricular assist device therapy
- Pages: 1631-1636
- First Published: 10 February 2021
Open Access
oa
Simple equations to predict the effects of veno-venous ECMO in decompensated Eisenmenger syndrome
- Pages: 1637-1642
- First Published: 25 February 2021
Open Access
oa
Acute heart transplantation from mechanical circulatory support in a human immunodeficiency virus-positive patient with fulminant myocarditis
- Pages: 1643-1648
- First Published: 25 February 2021
Study Designs
Open Access
oa
PRADOC: a trial on the efficiency of a transition care management plan for hospitalized patients with heart failure in France
- Pages: 1649-1655
- First Published: 25 December 2020
Open Access
oa
Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild-type cardiac amyloidosis
- Pages: 1656-1665
- First Published: 22 December 2020
Open Access
oa
Catheter ablation for atrial fibrillation in patients with end-stage heart failure and eligibility for heart transplantation
- Pages: 1666-1674
- First Published: 13 December 2020
Open Access
oa
Real-world outcomes in cardiac resynchronization therapy patients: design and baseline demographics of the SMART- Registry
- Pages: 1675-1680
- First Published: 19 January 2021
Short Communications
Open Access
oa
Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction
- Pages: 1681-1686
- First Published: 29 January 2021
Open Access
oa
Preserved ejection fraction and structural heart disease in 446 848 patients investigated with echocardiography
- Pages: 1687-1690
- First Published: 22 December 2020
Open Access
oa
Impact of COVID-19 on inpatient referral of acute heart failure: a single-centre experience from the south-west of the UK
- Pages: 1691-1695
- First Published: 06 January 2021
Open Access
oa
Time course of red cell volume and plasma volume over six months in compensated chronic heart failure
- Pages: 1696-1699
- First Published: 05 January 2021
Open Access
oa
Circulating multimarker approach to identify patients with preclinical left ventricular remodelling and/or diastolic dysfunction
- Pages: 1700-1705
- First Published: 12 February 2021
Open Access
oa
Acute pulmonary pressure change after transition to sacubitril/valsartan in patients with heart failure reduced ejection fraction
- Pages: 1706-1710
- First Published: 31 January 2021
Open Access
oa
Type 2 diabetes and heart failure: insights from the global DISCOVER study
- Pages: 1711-1716
- First Published: 11 February 2021
Open Access
oa
Influence of renin-angiotensin-aldosterone system inhibitors on plasma levels of angiotensin-converting enzyme 2
- Pages: 1717-1721
- First Published: 19 February 2021
Letters to the Editor
Open Access
oa
Meta-analysis of the effects of four factors on the efficacy of SGLT2 inhibitors in patients with HFrEF
- Pages: 1722-1724
- First Published: 05 February 2021
Open Access
oa
Comment on: Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: Rationale and design of SHIFT-AHF trial
- Pages: 1725-1726
- First Published: 27 February 2021
Open Access
oa
Myotonic dystrophy patients: More data about cardiac and neurologic findings would be useful
- Page: 1727
- First Published: 31 January 2021
Letter to the Editor - Reply
Open Access
oa
Reply to: Left ventricular midwall fibrosis as a predictor of sudden cardiac death in non-ischaemic dilated cardiomyopathy: a meta-analysis
- Page: 1728
- First Published: 18 January 2021
Open Access
oa
Reply to: More data about cardiac and neurologic findings would be useful
- Pages: 1729-1730
- First Published: 20 January 2021